News
Behemoth health insurers claim this time-wasting practice improves care and saves everyone money. Look beyond the myths and find out the facts.
Legislation focused on prior authorization reforms is headed to the governor after Senate lawmakers approved changes to the ...
Legislation focused on prior authorization reforms is headed to the governor after Senate lawmakers approved changes to the ...
The Iowa legislature has unanimously voted to set deadlines for insurance companies being asked to authorize treatment, ...
The ETA is not technically a visa—the ETA system will grant travelers digital authorization to enter the country. However, you will still need to apply for an ETA prior to arrival. If you haven ...
For patient advocates and health economists, cases like Ekirch’s illustrate why prior authorization has become such a chronic pain point for patients and doctors. For 50 years, insurers have ...
The US Food and Drug Administration (FDA) has approved denosumab-bnht (Conexxence/Bomyntra), manufactured by Fresenius Kabi, for all indications of the reference ...
Rep. Mark Green (R-Tenn.) reintroduced a bill Thursday seeking to reform prior authorization requirements in Medicare, Medicare Advantage, and Part D prescription drug plans requiring only ...
Fresenius’ operating company Fresenius Kabi reached a global settlement with Amgen concerning their denosumab biosimilars, allowing launch in the U.S. in mid-2025 and in Europe later in H2 of 2025, ...
Several states are considering regulating how insurers can use AI in prior authorization. In January, a California law took effect that prohibits payers from making coverage decisions based solely on ...
Our state’s patient advocates and health care providers are committed to ensuring all North Dakotans have access to high-quality, medically necessary health care when they need it most.
Samsung Bioepis and Hanmi Pharmaceutical will jointly sell the osteoporosis treatment Prolia biosimilar (a copy of a biopharmaceutical) in the domestic market. Samsung Bioepis, the developer of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results